Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Schedules,Therapeutic_group
GlaxoSmithKline NZ Limited,Mepolizumab,widening access - removal of Asthma Control Test requirement for access to mepolizumab,Mepolizumab (Nucala),Community and Hospital,Respiratory System and Allergies
